ID: ALA4540950

Max Phase: Preclinical

Molecular Formula: C30H47N9O6S

Molecular Weight: 661.83

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nc2ccccc2s1

Standard InChI:  InChI=1S/C30H47N9O6S/c1-17(2)15-22(38-26(43)21(10-6-7-13-31)37-28(45)23(16-40)35-18(3)41)27(44)36-20(11-8-14-34-30(32)33)25(42)29-39-19-9-4-5-12-24(19)46-29/h4-5,9,12,17,20-23,40H,6-8,10-11,13-16,31H2,1-3H3,(H,35,41)(H,36,44)(H,37,45)(H,38,43)(H4,32,33,34)/t20-,21-,22-,23-/m0/s1

Standard InChI Key:  BLOFNYQHKSGSGE-MLCQCVOFSA-N

Associated Targets(Human)

Serine protease hepsin 242 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matriptase 677 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Thrombin 11687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Coagulation factor X 9693 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 661.83Molecular Weight (Monoisotopic): 661.3370AlogP: -0.13#Rotatable Bonds: 20
Polar Surface Area: 254.51Molecular Species: BASEHBA: 10HBD: 9
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.62CX Basic pKa: 11.43CX LogP: -1.72CX LogD: -5.94
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.04Np Likeness Score: -0.15

References

1. Damalanka VC, Han Z, Karmakar P, O'Donoghue AJ, La Greca F, Kim T, Pant SM, Helander J, Klefström J, Craik CS, Janetka JW..  (2019)  Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology.,  62  (2): [PMID:30571119] [10.1021/acs.jmedchem.8b01536]
2. Damalanka VC, Wildman SA, Janetka JW..  (2019)  Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin.,  10  (9): [PMID:31803403] [10.1039/C9MD00234K]

Source